ArticleBreast cancer research and treatment2022

Impact of the EndoPredict genomic assay on treatment decisions for oestrogen receptor-positive early breast cancer patients: benefits of physician selective testing.

Phuong Dinh et al.PubMed ↗Publisher ↗

No numbers read from the abstract.